Literature DB >> 4171519

Propranolol and hypoglycaemia.

W S Reveno, H Rosenbaum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4171519     DOI: 10.1016/s0140-6736(68)90272-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

Review 1.  Side effects and contraindications of beta-receptor blocking agents.

Authors:  H Lydtin
Journal:  Klin Wochenschr       Date:  1977-05-01

Review 2.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

3.  Can beta-blockers be used in diabetic patients?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1979-03       Impact factor: 9.546

Review 4.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

5.  The effect of propranolol on hypoglycaemia. Observations in five insulinoma patients.

Authors:  C Scandellari; M Zaccaria; C De Palo; N Sicolo; G Erle; G Federspil
Journal:  Diabetologia       Date:  1978-10       Impact factor: 10.122

Review 6.  Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure.

Authors:  Yana Anfinogenova; Elena V Grakova; Maria Shvedova; Kristina V Kopieva; Alexander T Teplyakov; Sergey V Popov
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

7.  Effects of propranolol on blood sugar, insulin and free fatty acids.

Authors:  S P Allison; M J Chamberlain; J E Miller; R Ferguson; A P Gillett; B V Bemand; R A Saunders
Journal:  Diabetologia       Date:  1969-10       Impact factor: 10.122

Review 8.  Formulary considerations in selection of beta-blockers.

Authors:  K C Yedinak
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

Review 9.  Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.

Authors:  D J Greenblatt; J Koch-Weser
Journal:  Drugs       Date:  1974       Impact factor: 9.546

10.  Beta-adrenergic blockade is more effective in suppressing adrenaline-induced glucose production in Type 1 (insulin-dependent) diabetes.

Authors:  H Shamoon; R Sherwin
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.